GeneralConnection.com ➔ Dictionary
Dictionary Search

polycythemia

Synonyms

Noun

1. blood disease

2. blood disorder

Usage
Dr Bose on the Rationale for Evaluating Sapablursen in Polycythemia Vera - OncLive
Health Canada approves Besremi for polycythemia vera - The Pharma Letter
PharmaEssentia Announces Health Canada Approval of BESREMi® (ropeginterferon alfa-2b) for Polycythemia Vera (PV) - Business Wire
Rusfertide Maintains Long-Term Thromboembolism Control in Phlebotomy-Dependent Polycythemia Vera - OncLive
Emerging Evidence for Earlier Intervention in Low-Risk Polycythemia Vera - Targeted Oncology
Polycythemia Vera Prevalence to Near 100K by 2030 as Symptom Burden Grows - AJMC
FDA Approves BESREMi Pen for Self-Administration in Polycythemia Vera - Oncology Nursing News
Potential Rusfertide Approval May Offer More Control of Polycythemia Vera - CancerNetwork
FDA Grants Priority Review to Rusfertide for Polycythemia Vera - Cure Today
Optimized post-GWAS analysis identifies therapeutic targets for essential thrombocythemia and polycythemia vera - Nature
Revisiting old drugs and drug combinations for polycythemia vera and related neoplasms - Frontiers
Hepcidin Modulation in Polycythemia Vera: Current Landscape and Next Steps - ASCO Daily News
LLM Tool Significantly Reduces Participant Screening Burdens, Improves Enrollment for Phase III Trial in Polycythemia Vera - The ASCO Post
FDA Clears Pen Device for Interferon Therapy in Polycythemia Vera - Targeted Oncology
Divesiran Reduces Phlebotomy Burden and Improves Iron Stores in Polycythemia Vera - OncLive
Impact of thrombosis on disease progression, cancer and mortality in patients with essential thrombocythemia and polycythemia vera - Nature
Optimizing Treatment Outcomes in Polycythemia Vera - Targeted Oncology
Dr Vachhani on Phase 2 Efficacy/Safety Data for Sapablursen in Polycythemia Vera - OncLive
Considerations in the First-Line Setting in Polycythemia Vera - Targeted Oncology
FDA Approves Prefilled Pen for Ropeginterferon Alfa-2b in Polycythemia Vera - OncLive
Rusfertide Earns FDA Priority Review in Polycythemia Vera - CancerNetwork
Rusfertide May Become Part of Polycythemia Vera Armamentarium - CancerNetwork
What Fatigue Feels Like for a Patient With Polycythemia Vera - Cure Today
Phase 2 Trial Begins for First-in-Class Polycythemia Vera Treatment - Docwire News
Navigating Resistance and Intolerance in High-Risk Polycythemia Vera - Targeted Oncology
GLP-1a Therapy Improves Survival in Patients with Polycythemia Vera and Myelodysplastic Syndromes - Cleveland Clinic
Phlebotomy Burden Undermines Consistent PV Control - AJMC
Developers Submit NDA to FDA for Rusfertide in Polycythemia Vera - CancerNetwork
JAK Inhibitors Expand Treatment Options in Polycythemia Vera and Myelofibrosis - OncLive
Interferons in Polycythemia Vera Management - HMP Global Learning Network
Polycythemia Vera Market Set for Transformation: Key 9 Companies Expected to Enter by 2036 | DelveInsight - Yahoo Finance
Sequential Transformation of Polycythemia Vera to Myelofibrosis and KMT2A-Rearranged Acute Myeloid Leukemia Treated With Revumenib: A Rare Case of Clonal Evolution - Cureus
SANRECO Trial Explores Divesiran for Polycythemia Vera Treatment - Cure Today
GLP-1 Therapy Linked to Improved Outcomes in Polycythemia Vera - Cure Today
Aaron Gerds, MD, on Using an AI System to Identify Patients Eligible for a Polycythemia Vera Trial - The ASCO Post
Low neutrophil-to-lymphocyte ratio identifies secondary polycythemia in patients with erythrocytosis - Nature
Rusfertide Continues to Show Strong Results for Polycythemia Vera - OncLive
FDA Clears Once-Daily Ruxolitinib Tablets for Myelofibrosis, Polycythemia Vera, and GVHD - OncLive
Dr Desai on the Treatment Landscape of Polycythemia Vera - OncLive
Weekly injection a potential new treatment option for polycythemia vera - Wiley & Sons
Breaking Down the Standard of Care for Patients With Polycythemia Vera - Cure Today
FDA Accepts New Drug Application for Rusfertide, Grants Priority Review In Polycythemia Vera - HCPLive
Retroperitoneal and Pelvic Myeloid Sarcoma in a Patient With JAK2-Positive Polycythemia Vera: A Case Report - Cureus
Key Link Found in Ropeginterferon Treatment for Polycythemia Vera - Docwire News
FDA Approves Ruxolitinib Extended-Release Tablets for Myelofibrosis, Polycythemia Vera, and GVHD - Docwire News
NDA Submitted to FDA for Rusfertide for Polycythemia Vera - OncLive
FDA Grants Priority Review to Rusfertide in Polycythemia Vera - OncLive
GLP-1 Agonists Show Therapeutic Benefits in Polycythemia Vera Population - CancerNetwork
FDA Grants Breakthrough Therapy Designation to Rusfertide for Erythrocytosis in Polycythemia Vera - OncLive
ASH: Merck mulls future of polycythemia program while Takeda takes phase 3 victory lap - Fierce Biotech
suppression and event-free survival in polycythemia vera - Nature
Treating Low-Risk Polycythemia Vera in the Second Line - Targeted Oncology
Weight-Loss Drugs for Polycythemia Vera? - Medscape
Novartis Korea's Jakavi wins reimbursement for 2nd-line treatment of polycythemia vera - koreabiomed.com
Rusfertide Earns FDA BTD for Erythrocytosis in Polycythemia Vera - CancerNetwork
Dr Jain on Persisting Gaps in Defining Disease Modification in Polycythemia Vera and Myelofibrosis - OncLive
Polycythemia Vera and Essential Thrombocythemia: A Nationwide Population‐Based Study on Treatment Patterns, Vascular Complications and Survival - Larsson - 2026 - European Journal of Haematology - Wiley Online Library
Dr Kuykendall on Quality of Life Outcomes With Rusfertide in Polycythemia Vera - OncLive
Rampal Analyzes Ropeginterferon Data in Low-Risk Polycythemia Vera - Targeted Oncology
Dr Jain on the Role of Ruxolitinib in Polycythemia Vera and Myelofibrosis - OncLive
Considerations for Selection and Sequencing in Polycythemia Vera and Myelofibrosis - OncLive
Rusfertide Earns Breakthrough Therapy Designation in Polycythemia Vera - Cure Today
Divesiran Shows Promise as RNA-Based Approach in Polycythemia Vera - OncLive
The use of ropeginterferon alpha-2b in the treatment of polycythemia vera in a young patient with joint pain - Via Medica Journals
Dr Kremyanskaya on the Ongoing Development of Divesiran for Polycythemia Vera - OncLive
Dr. Roach: Symptoms, not numbers, are the main drivers for a phlebotomy - The Detroit News
Takeda and Protagonist Announce Submission of Rusfertide NDA for Polycythemia Vera - HCPLive
Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera - Business Wire
When Rusfertide May Become Accessible for Those with Polycythemia Vera - Cure Today
New Therapies Advance for Rare Blood Cancer Polycythemia Vera - Cure Today
Vanda Pharmaceuticals Announces FDA Granted Orphan Drug Designation for VGT-1849B, a Novel and Selective Candidate for the Treatment of Polycythemia Vera - PR Newswire
Addressing the Hidden Burden of Polycythemia Vera: Andrew Kuykendall, MD - AJMC
AN2 Therapeutics Announces Plans to Advance Oral Epetraborole into Phase 2 Study for Polycythemia Vera (PV) - Business Wire
Rusfertide Gains Breakthrough Therapy Designation for Polycythemia Vera - Pharmacy Times – Pharmacy Practice News and Expert Insights
Rusfertide Poised to Transform Polycythemia Vera Care: Andrew Kuykendall, MD - AJMC
Different Colours of Polycythemia Vera: A Case Series - Cureus
Polycythemia Vera: Practice Essentials, Pathophysiology, Etiology - Medscape
Rusfertide Cuts Number of Needed Blood Draws to Treat PCV - National Cancer Institute (.gov)
A molecular signature predicts hematologic evolution in polycythemia vera patients | Leukemia - Nature
Diagnosis and Management of PV and ET in Pediatric Populations Needs Improvement - Hematology Advisor
Rusfertide, a Hepcidin Mimetic, for Control of Erythrocytosis in Polycythemia Vera - The New England Journal of Medicine
Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b - Nature
Polycythemia vera: 2024 update on diagnosis, risk‐stratification, and management - Wiley Online Library
Impact of treatment for adolescent and young adults with essential thrombocythemia and polycythemia vera | Leukemia - Nature
The Evolving Landscape of Polycythemia Vera Treatment - Pharmacy Times – Pharmacy Practice News and Expert Insights
FDA Gives Fast Track Designation to Givinostat for Polycythemia Vera - CancerNetwork
Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment | Leukemia - Nature
Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera - The New England Journal of Medicine
VERIFY: Novel Polycythemia Vera Treatment Reduces Disease Burden, Improves Quality of Life in Patients With Phlebotomy-Dependent Disease - ASCO Daily News
Polycythemia vera treatment algorithm 2018 - Nature
Expanding on a New Way to Manage Polycythemia Vera Without Iron Deficiency - Cure Today
Polycythemia Vera: A Comprehensive Approach to Management - Hematology Advisor
FDA Grants Fast Track Designation to Givinostat for Polycythemia Vera - OncLive
Typical Presentation of Polycythemia Vera - Targeted Oncology
Polycythemia Vera Diagnostic Workup - Targeted Oncology
Prediction of resistance to hydroxyurea therapy in patients with polycythemia vera: a machine learning study (PV-AIM) validated in a prospective interventional phase IV trial (HU-F-AIM) - Nature
Mortality Rates, Diverse Causes of Death in Polycythemia Vera - Hematology Advisor
Understanding Hematocrit Thresholds in Polycythemia Vera Treatment - AJMC
Identification of Hepatic-like EPO as a Cause of Polycythemia - The New England Journal of Medicine
Rusfertide Shines as New Treatment Option in Polycythemia Vera - OncLive
Foreign Language Equivalents
Foreign Language Equivalents of 'polycythemia'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
polycyythemia,   oolycythemia,   pplycythemia,   polycythemiaa,   polyythemia,   polycythmia,   polycytgemia,   polucythemia,   polycythemoa,   polycyyhemia,   polyctyhemia,   [olycythemia,   polyvythemia,   poolycythemia,   polycytjemia,   poltcythemia,   polyycthemia,   polcythemia,   polycythenia,   po;ycythemia,   polyccythemia,   polycythhemia,   polycythwmia,   polycyhtemia,   polycythemua,   ploycythemia,   polycytheima,   polycythemis,   pollycythemia,   poycythemia,   poylcythemia,   polycytthemia,   polycytheemia,   plycythemia,   olycythemia,   polyxythemia,   polycythema,   polycythemai,   pilycythemia,   pokycythemia,   polycthemia,   polycythmeia,   polycythemmia,   polycythe,ia,   polycyrhemia,   polycytehmia,   polyycythemia,   polycyhemia,   ppolycythemia,   polycytemia,   polcyythemia,   polycythrmia,   polycythemi,   polycythemiia,   polycytheia,   oplycythemia,   polycuthemia,   polyctthemia
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z